https://onlinelibrary.wiley.com/page/journal/23301619/homepage/mdc312920-sup-v001.htm
https://onlinelibrary.wiley.com/page/journal/23301619/homepage/mdc312920-sup-v002.htm
https://onlinelibrary.wiley.com/page/journal/23301619/homepage/mdc312920-sup-v003.htm
Niemman Pick type C (NPC) is a treatable neurodegenerative lysosomal disorder characterized by the widespread age of onset and clinical presentation. The adult NPC phenotype frequently includes ataxia, supranuclear gaze palsy, and cognitive and behavioral problems.1 Movement disorders are also often observed in these patients. Among them, chorea has been rarely described as a dominant sign.1, 2 On the other hand, a phenotype dominated by chorea and cognitive and behavioral manifestations is suggestive of Huntington's disease (HD).3, 4 The rare cases showing this phenotype proved to be negative for the CAG expansion in HTT and are categorized as Huntington‐like disorders (HDL).5 Although the list of HDL genetic etiologies has grown considerably during the past few years, the diagnostic yield for these conditions is still limited.3, 5 Noteworthy, NPC is neither routinely considered in the differential diagnosis of chorea nor among the HDL disorders. We present 2 siblings presenting with a late onset and predominate choreic phenotype, where the final diagnosis was NPC.
Case Report
Case 1
A 58‐year‐old man was referred to our center for evaluation of an HDL disorder as the result of the presence of chorea, cognitive impairment, psychiatric symptoms, and a normal molecular study for HD. He was healthy until the age of 40, when a progressive complex neuropsychiatric disorder started. Depressive mood and apathy were present at the beginning, whereas cognitive decline and visual hallucinations became evident during the first 5 years of disease. Neurological examination at our first consultation was remarkable for the presence of generalized chorea, inability to sustain tongue protrusion, slowed horizontal saccades, and vertical supranuclear gaze palsy (VSGP; Video S1). An abridged evaluation indicated severe cognitive impairment as well. Magnetic resonance imaging (MRI) of the brain showed no abnormalities. Initial routine laboratory testing was uninformative. We ruled out HD, finding a normal number of repeat expansions in both alleles (17 and 19 CAG repeats) of the HTT gene. Following our molecular diagnostic algorithm for HDL cases, we ruled out mutations in the TBP and C9orf72 genes as well.
Case 2
The sister of case I was a 42‐year‐old woman with a previous diagnosis of schizophrenia at the age of 17 when she presented with visual and auditory hallucinations. She was chronically treated with neuroleptics for control of her psychiatric symptoms. She was free of other significant impairments until the age of 40, when involuntary choreic movements in the upper and lower limbs started. Cognitive decline became evident a few months later. At the time of our first consultation, we found signs of severe cognitive impairment, slurred speech, slowed horizontal saccades, and severe VSGP along a manifest impairment in maintaining motor postures and positions. Choreic movements were present in the upper and lower limbs also affecting her gait (Video S2). MRI of the brain and initial laboratory testing were unremarkable.
The presence of VSGP in both patients, despite a predominate choreic phenotype, led us to rule out NPC. Accordingly, we assessed in the proband the concentration of the lyso‐SM‐509 biomarker in blood using high‐performance liquid chromatography/tandem mass spectrometry (CentoGene, AG (PB), Rostock, Germany). We found a marked increment in its levels. NPC was thereafter confirmed by Sanger sequencing of the NPC1 gene, where we identified compound heterozygosity for 2 novel likely pathogenic variants (c.1672G > A;p.Ala558Thr and c.3249_3250delGT;p.Phe1084Leufs*12). Treatment with miglustat (600 mg/day) was started in case 1.
Discussion
We described 2 siblings presenting with a choreic and late‐onset NPC phenotype that were initially categorized as HD phenocopies. Chorea has been described in about 19% of NPC patients1; however, all previous reports have described this involuntary movement as part of complex phenotypes that invariably include more typical features of NPC as predominant clinical manifestations, such as visceral compromise, dystonia, or ataxia.1 Furthermore, none of these cases were mentioned as an HDL. The prevalence of HD phenocopies is probably larger than previously thought.5 Moreover, the list of its etiologies is heterogeneous and expanding. Even comprehensive approaches, investigating abnormalities in 63 genes in a cohort of patients presenting with HD phenotypes, have not included NPC1 and NPC2 as etiologic candidates.6 Nevertheless, the majority of patients presenting initially as HDL progress to include clinical features that often are characteristic of the condition finally identified. We think that our patients showed this evolution as well, where the appearance of VSGP was the key for suspecting and investigating NPC. It is present in about 75% of the adult form of NPC.1 However, other neurodegenerative conditions show impairments in eye movements as well.7 Abnormalities in ocular motility and saccades are frequent in HD as well.8 The evaluation of HD patients typically shows increased saccade latency and saccade slowing affecting both the vertical and horizontal planes.9
NPC may be underdiagnosed because of its wide spectrum of clinical manifestations. Our cases highlight that NPC can mimic and should be considered in the diagnostic approach of patients of any age with a predominant choreic phenotype. Its recognition is of paramount importance for an early and correct diagnosis with a therapeutic relevance.
Author Roles
(1) Manuscript Preparation: A. Writing of the First Draft, B. Review and Critique.
S.R.Q.: 1A, 1B
L.Z.: 1A, 1B
J.P.M.: 1A, 1B
D.G.‐M.: 1B
N.G.: 1B
M.A.K.: 1B
Disclosures
Ethical Compliance Statement: We confirm that we have read the Journal's position on issues involved in ethical publication and affirm that this work is consistent with those guidelines. The authors confirm that the patient provided verbal and written consent for this work but because this article is a case report no institutional review board approval was necessary.
Funding Sources and Conflict of Interest: No specific funding was received for this work. The authors declare that there are no conflicts of interest relevant to this work.
Financial Disclosures for the Previous 12 Months: S.R.Q. has received scholarship support from Ministry of Health of Buenos Aires City. L.Z., D.G.‐M., and N.G. declare that there are no additional disclosures to report. J.P.M. has received scholarship support from Argentinean National Science Council. M.A.K. has received grant support from Ministry of Health of Buenos Aires City, Argentinean National Science Council, and Argentinean Ministry of Science and Technology. He serves as associate editor of the journal Neurologia Argentina.
Supporting information
Relevant disclosures and conflicts of interest are listed at the end of this article.
References
- 1. Sévin M, Lesca G, Baumann N, et al. The adult form of Niemann‐Pick disease type C. Brain. 2007;130:120–33. [DOI] [PubMed] [Google Scholar]
- 2. Anheim M, Lagha‐Boukbiza O, Fleury‐Lesaunier MC, et al. Heterogeneity and frequency of movement disorders in juvenile and adult‐onset Niemann‐Pick C disease. J Neurol. 2014;261:174–9. [DOI] [PubMed] [Google Scholar]
- 3. Schneider SA, Bird T. Huntington's disease, Huntington's disease look‐alikes, and benign hereditary chorea: what's new? Mov Disord Clin Pract 2016;3(4):342–354. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Ghosh R, Tabrizi SJ. Huntington disease. Handb Clin Neurol 2018;147:255–278. [DOI] [PubMed] [Google Scholar]
- 5. Wild EJ, Tabrizi SJ. Huntington's disease phenocopy syndromes. Curr Opin Neurol 2007;20(6):681–687. [DOI] [PubMed] [Google Scholar]
- 6. Mariani LL, Tesson C, Charles P, Cazeneuve C, et al. Expanding the spectrum of genes involved in Huntington disease using a combined clinical and genetic approach. JAMA Neurol. 2016;73:1105–14. [DOI] [PubMed] [Google Scholar]
- 7. Salsano E, Umeh C, Rufa A, Pareyson D, Zee DS. Vertical supranuclear gaze palsy in Niemann‐Pick type C disease. Neurol Sci. 2012;33:1225–32. [DOI] [PubMed] [Google Scholar]
- 8. Attoni T, Beato R, Pinto S, Cardoso F. Abnormal eye movements in three types of chorea. 2016;761–6. [DOI] [PubMed]
- 9. Anderson TJ, MacAskill MR. Eye movements in patients with neurodegenerative disorders. Nat Rev Neurol 2013;9(2):74–85. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.